Journal: Molecular Medicine Reports
Article Title: Amygdalin ameliorates the progression of atherosclerosis in LDL receptor-deficient mice
doi: 10.3892/mmr.2017.7609
Figure Lengend Snippet: Protein expression levels of CD68, MCP-1, MMP-2 and MMP-9. (A) Western blot analysis demonstrated that amygdalin treatment reduced the protein levels of CD68, MCP-1, MMP-2 and MMP-9. (B) Relative mRNA levels were quantified. Data are presented as the mean ± standard error of the mean from three independent experiments. *P<0.05 and **P<0.01. LDLR −/− , low-density lipoprotein receptor deficiency; MCP-1, monocyte chemoattractant protein-1; MMP, matrix metalloproteinase.
Article Snippet: The mouse monoclonal CD68 (cat. no. sc-20060; 1:1,000), mouse monoclonal MMP-2 (cat. no. sc-13594; 1:500), mouse monoclonal MMP-9 (cat. no. sc-393859; 1:500) and mouse monoclonal β-actin (cat. no. sc-47778; 1:5,000) were purchased from Santa Cruz Biotechnology (Dallas, TX, USA).
Techniques: Expressing, Western Blot